HORIZON PHARMA PLC's ticker is HZNPXXXX and the CUSIP is G4617B105. A total of 182 filers reported holding HORIZON PHARMA PLC in Q3 2017. The put-call ratio across all filers is 0.37 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2019 | $11,827,000 | +133.6% | 491,544 | +156.6% | 0.15% | +129.7% |
Q1 2019 | $5,063,000 | +35.3% | 191,544 | 0.0% | 0.06% | +18.5% |
Q4 2018 | $3,743,000 | -45.6% | 191,544 | -45.5% | 0.05% | -38.6% |
Q3 2018 | $6,879,000 | -0.0% | 351,349 | -15.4% | 0.09% | -7.4% |
Q2 2018 | $6,880,000 | +72.3% | 415,485 | +47.7% | 0.10% | +55.7% |
Q1 2018 | $3,994,000 | -20.2% | 281,300 | -18.0% | 0.06% | -15.3% |
Q4 2017 | $5,006,000 | +3.0% | 342,894 | -10.5% | 0.07% | +4.3% |
Q3 2017 | $4,858,000 | +5.4% | 383,148 | -1.3% | 0.07% | -1.4% |
Q2 2017 | $4,609,000 | -5.7% | 388,284 | +17.4% | 0.07% | -15.7% |
Q1 2017 | $4,888,000 | +6.5% | 330,709 | +16.6% | 0.08% | -6.7% |
Q4 2016 | $4,589,000 | -66.1% | 283,640 | -62.1% | 0.09% | -62.8% |
Q3 2016 | $13,554,000 | +23.7% | 747,600 | +12.4% | 0.24% | +13.8% |
Q2 2016 | $10,953,000 | -0.1% | 665,000 | +0.5% | 0.21% | -0.9% |
Q1 2016 | $10,961,000 | -23.5% | 661,500 | 0.0% | 0.21% | -15.5% |
Q4 2015 | $14,335,000 | – | 661,500 | – | 0.25% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Scale Management, LLC | 1,710,451 | $59,421,000 | 38.70% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 12,259,875 | $425,908,000 | 14.19% |
Broadfin Capital, LLC | 4,815,807 | $167,301,000 | 8.99% |
JW Asset Management, LLC | 766,724 | $26,636,000 | 8.10% |
Marble Arch Investments | 1,888,000 | $65,589,000 | 5.65% |
HealthCor Management, L.P. | 3,200,000 | $111,168,000 | 5.60% |
Beach Point Capital Management LP | 794,290 | $27,594,000 | 5.42% |
KINGDON CAPITAL MANAGEMENT, L.L.C. | 3,325,829 | $115,539,000 | 4.52% |
Ratan Capital Management LP | 1,321,300 | $45,902,000 | 4.37% |
Green Owl Capital Management, LLC | 130,000 | $4,516,000 | 3.22% |